0 NASDAQ Companies - December 2, 2024Credo Reports Second Quarter of Fiscal Year 2025 Financial ResultsSAN JOSE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) — Credo Technology Group Holding Ltd (Nasdaq: CRDO), an innovator in providing […]Read More
0 NASDAQ Companies - December 2, 2024vTv Therapeutics to Participate in 7th Annual Evercore HealthCONx ConferenceHIGH POINT, N.C., Dec. 02, 2024 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company with […]Read More
0 NASDAQ Companies - December 2, 2024OrthoPediatrics Corp. to Host Educational and Networking Events at 20th Annual International Pediatric Orthopaedic Symposium (IPOS)WARSAW, Ind., Dec. 02, 2024 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively […]Read More
0 NASDAQ Companies - December 2, 2024Zscaler Reports First Quarter Fiscal 2025 Financial ResultsFirst Quarter Highlights Revenue grows 26% year-over-year to $628.0 million Calculated billings grows 13% year-over-year to $516.7 million Deferred revenue […]Read More
0 NASDAQ Companies - December 2, 2024Interparfums, Inc. To Develop Off-White Brand in Fragrance and Beauty CategoryNEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) — Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced that […]Read More
0 NASDAQ Companies - December 2, 2024Inari Medical Announces Joint Venture in Greater ChinaIRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a […]Read More
0 NASDAQ Companies - December 2, 2024NKGen Biotech Selected as Stalking Horse Bidder for NKMaxUpon closing, the transaction would secure global IP rights for NKGen. NKGen and its partners can begin to commercialize troculeucel […]Read More
0 NASDAQ Companies - December 2, 2024Nasdaq Reports November 2024 VolumesNEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for November 2024 on its […]Read More